TCRT vs TLPH

Alaunos Therapeutics, Inc. vs Talphera, Inc. — Valuation Comparison 2026

TCRT

Pharmaceutical Preparations
Alaunos Therapeutics, Inc.
Quality
4.4
out of 10
Value Trap
33
LOW
Price
$2.85
Last close
Models
8/13
Active
VS

TLPH

Pharmaceutical Preparations
Talphera, Inc.
Quality
5.6
out of 10
Value Trap
51
WARN
Price
$0.82
Last close
Models
9/13
Active

Model-by-Model Comparison

ModelType TCRT Fair ValueTCRT Upside TLPH Fair ValueTLPH Upside
Bayesian DCF Intrinsic $0.72 -74.6% $0.26 -68.5%
First Chicago Scenario $•••.•• ••.•% $•••.•• ••.•%
ML-RIV Intrinsic $0.09 -96.4% $0.03 -96.6%
Dynamic NAV Asset-Based $0.68 -17.0%
PWERM Option-Based $•••.•• ••.•% $•••.•• ••.•%
Regime Cross-Sectional Relative $•••.•• ••.•% $•••.•• ••.•%
Sentiment SOTP Hybrid $•••.•• ••.•% $•••.•• ••.•%
CUCE Ensemble Ensemble $•••.•• ••.•% $•••.•• ••.•%
FTNN Topology Relative $•••.•• ••.•% $•••.•• ••.•%
🔒

Unlock Full 13-Model Comparison

Access all valuation models for TCRT vs TLPH — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

TCRT vs TLPH — Which Stock Is More Undervalued?

TLPH scores higher with a 5.6/10 quality rating vs TCRT's 4.4/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Alaunos Therapeutics, Inc. (TCRT) and Talphera, Inc. (TLPH) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

TCRT currently trades at $2.85 with a QOC of 4.4/10, while TLPH trades at $0.82 with a QOC of 5.6/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).